Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative esketamine for depression in infertility and pregnancy loss patients
ChiCTR2000040404Phase 4Not yet recruiting
- Sponsor
- Shenzhen Maternal and Child Health Hospital
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in major depressive disorder (MDD) (2 arms), sponsored by Shenzhen Maternal and Child Health Hospital. Primary endpoint: BDI-II (Beck Depression Inventory-II) score. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2000040404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040404.